Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Sterility & contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections.

6,317 FDA drug recalls with this cause, newest first.

This is the single biggest cause in the register by a wide margin. It covers products that had to be sterile - injectables, eye drops, certain ointments - but could not be verified sterile, or were found contaminated during testing. Most of these recalls come from compounding pharmacies and outsourcing facilities after an FDA inspection finds gaps in how sterile products were made. Sterility failures are treated seriously because the products involved have the least room for error, going straight into the bloodstream or the eye.

Class II · Moderate risk

Bevacizumab

Lack of Assurance of Sterility: Leiter Pharmacy is recalling due bacterial contamination found after investigation at contract testing laboratory discovered that OOS/failed results were reported to customers as passing. Hence the sterility of the products cannot be assured.

Terminated Sterility / contamination Leiter's Pharmacy D-1040-2013
Class II · Moderate risk

Hyaluron (hyaluronidase)

Lack of Assurance of Sterility: Leiter Pharmacy is recalling due bacterial contamination found after investigation at contract testing laboratory discovered that OOS results were reported to customers as passing. Hence the sterility of these products cannot be assured.

Terminated Sterility / contamination Leiter's Pharmacy D-1039-2013
Class II · Moderate risk

Dextrose 50% Preservative Free SDV Injection Solution

Lack of Assurance of Sterility: Leiter Pharmacy is recalling due bacterial contamination found after investigation at contract testing laboratory discovered that OOS results were reported to customers as passing. Hence the sterility of these products cannot be assured.

Terminated Sterility / contamination Leiter's Pharmacy D-1038-2013
Class II · Moderate risk

Lidocaine 1% PF Sterile Injection

Lack of Assurance of Sterility: Pharmacy Creations is recalling Lidocaine 1% PF Sterile Injection and EDTA disodium 150 mg/mL due to lack of assurance of sterility.

Terminated Sterility / contamination Pharmacy Creations D-1028-2013
Class II · Moderate risk

NA Ascorbate 500 mg/mL

Lack of Assurance of Sterility: The product lots are being recalled due to laboratory results (from a contract lab) indicating microbial contamination. The FDA was concerned test results obtained from the recalling firm's contract testing lab may not be reliable. Hence the sterility of the products cannot be assured.

Terminated Sterility / contamination Medaus, Inc. D-1055-2013
Class II · Moderate risk

NA Ascorbate 500 mg/mL

Lack of Assurance of Sterility: The product lots are being recalled due to laboratory results (from a contract lab) indicating microbial contamination. The FDA was concerned test results obtained from the recalling firm's contract testing lab may not be reliable. Hence the sterility of the products cannot be assured.

Terminated Sterility / contamination Medaus, Inc. D-1054-2013
Class II · Moderate risk

Magnesium Chl 200 mg/mL PF

Lack of Assurance of Sterility: The product lots are being recalled due to laboratory results (from a contract lab) indicating microbial contamination. The FDA was concerned test results obtained from the recalling firm's contract testing lab may not be reliable. Hence the sterility of the products cannot be assured.

Terminated Sterility / contamination Medaus, Inc. D-1053-2013
Class II · Moderate risk

Pyridoxine HCL 100 mg/mL NS

Lack of Assurance of Sterility: The product lots are being recalled due to laboratory results (from a contract lab) indicating microbial contamination. The FDA was concerned test results obtained from the recalling firm's contract testing lab may not be reliable. Hence the sterility of the products cannot be assured.

Terminated Sterility / contamination Medaus, Inc. D-1052-2013
Class II · Moderate risk

L-Glutathione 200 mg/mL PF

Lack of Assurance of Sterility: The product lots are being recalled due to laboratory results (from a contract lab) indicating microbial contamination. The FDA was concerned test results obtained from the recalling firm's contract testing lab may not be reliable. Hence the sterility of the products cannot be assured.

Terminated Sterility / contamination Medaus, Inc. D-1051-2013
Class II · Moderate risk

Taurine 50 mg/mL PF

Lack of Assurance of Sterility: The product lots are being recalled due to laboratory results (from a contract lab) indicating microbial contamination. The FDA was concerned test results obtained from the recalling firm's contract testing lab may not be reliable. Hence the sterility of the products cannot be assured.

Terminated Sterility / contamination Medaus, Inc. D-1050-2013
Class II · Moderate risk

Lipo-Injection w/ Lidocaine

Lack of Assurance of Sterility: The product lots are being recalled due to laboratory results (from a contract lab) indicating microbial contamination. The FDA was concerned test results obtained from the recalling firm's contract testing lab may not be reliable. Hence the sterility of the products cannot be assured.

Terminated Sterility / contamination Medaus, Inc. D-1049-2013
Class II · Moderate risk

Testosterone Cyp 200 mg/mL

Lack of Assurance of Sterility: The product lots are being recalled due to laboratory results (from a contract lab) indicating microbial contamination. The FDA was concerned test results obtained from the recalling firm's contract testing lab may not be reliable. Hence the sterility of the products cannot be assured.

Terminated Sterility / contamination Medaus, Inc. D-1048-2013
Class II · Moderate risk

Epinephrine 1:1

Lack of Assurance of Sterility: The product lots are being recalled due to laboratory results (from a contract lab) indicating microbial contamination. The FDA was concerned test results obtained from the recalling firm's contract testing lab may not be reliable. Hence the sterility of the products cannot be assured.

Terminated Sterility / contamination JCB Labs LLC D-1047-2013
Class II · Moderate risk

Sodium Citrate 4% Solution for Injection

Lack of Assurance of Sterility: The product lots are being recalled due to laboratory results (from a contract lab) indicating microbial contamination. The FDA was concerned test results obtained from the recalling firm's contract testing lab may not be reliable. Hence the sterility of the products cannot be assured.

Terminated Sterility / contamination JCB Labs LLC D-1046-2013
Class II · Moderate risk

Sodium Citrate 4% containing Gentamicin 320 mcg/mL

Lack of Assurance of Sterility: The product lots are being recalled due to laboratory results (from a contract lab) indicating microbial contamination. The FDA was concerned test results obtained from the recalling firm's contract testing lab may not be reliable. Hence the sterility of the products cannot be assured.

Terminated Sterility / contamination JCB Labs LLC D-1045-2013
Class II · Moderate risk

Sodium Thiosulfate 25%

Lack of Assurance of Sterility: The product lots are being recalled due to laboratory results (from a contract lab) indicating microbial contamination. The FDA was concerned test results obtained from the recalling firm's contract testing lab may not be reliable. Hence the sterility of the products cannot be assured.

Terminated Sterility / contamination JCB Labs LLC D-1044-2013
Class II · Moderate risk

Acetylcysteine 20% Solution

Lack of Assurance of Sterility: The product lots are being recalled due to laboratory results (from a contract lab) indicating microbial contamination. The FDA was concerned test results obtained from the recalling firm's contract testing lab may not be reliable. Hence the sterility of the products cannot be assured.

Terminated Sterility / contamination JCB Labs LLC D-1043-2013
Class II · Moderate risk

Dexpanthenol 250 mg/mL PF

Lack of Assurance of Sterility: The product lots are being recalled due to laboratory results indicating microbial contamination. The FDA was concerned test results obtained from the recalling firm's contract testing lab may not be reliable.

Terminated Sterility / contamination Wellness Pharmacy, Inc. D-1035-2013
Class II · Moderate risk

RL Glutathione 100 mg/mL

Lack of Assurance of Sterility: The product lots are being recalled due to laboratory results indicating microbial contamination. The FDA was concerned test results obtained from the recalling firm's contract testing lab may not be reliable.

Terminated Sterility / contamination Wellness Pharmacy, Inc. D-1034-2013
Class II · Moderate risk

NA. Phenylbutyrate 200 mg/mL

Lack of Assurance of Sterility: The product lots are being recalled due to laboratory results indicating microbial contamination. The FDA was concerned test results obtained from the recalling firm's contract testing lab may not be reliable.

Terminated Sterility / contamination Wellness Pharmacy, Inc. D-1033-2013
Class II · Moderate risk

Methyl B12 1 mg/mL P.F.

Lack of Assurance of Sterility: The product lots are being recalled due to laboratory results indicating microbial contamination. The FDA was concerned test results obtained from the recalling firm's contract testing lab may not be reliable.

Terminated Sterility / contamination Wellness Pharmacy, Inc. D-1032-2013
Class II · Moderate risk

Magnesium Sulfate Hepta 50% PF

Lack of Assurance of Sterility: The product lots are being recalled due to laboratory results indicating microbial contamination. The FDA was concerned test results obtained from the recalling firm's contract testing lab may not be reliable.

Terminated Sterility / contamination Wellness Pharmacy, Inc. D-1031-2013
Class II · Moderate risk

Testosterone Cypionate

Lack of Assurance of Sterility: Park Compounding is voluntarily recalling two lots of Methylcobalamin 5mg/ml and Multitrace-5 Concentrate, and one lot of Testosterone Cypionate (sesame oil) for injection due lack of sterility assurance.

Terminated Sterility / contamination South Coast Specialty Compounding, Inc. D-1027-2013